#Biocon, the Global Biopharmaceuticals Company of #India, on Friday Said Its #Q2FY22 ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#Biocon, the global biopharmaceuticals company of #India, on Friday said its #Q2FY22 revenue growth was up by 10 per cent at Rs 1,945 crore, primarily driven by good performance of the Research Services and Biosimilars business segments.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)